UTI Company Profile and Key Details

UTI has shown mixed momentum, losing -1.7% over the past week and -11.58% over the past quarter, though year-to-date performance is up 4.06%. Short-term trend indicators are mixed aligned (SMA20 16.32%, SMA50 22.39%, SMA200 15.77%). The stock’s 14-day RSI is 69.97 (firm momentum), while the ATR of 1.55 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -5.29% below its high and over 61.58% above its low. Average 10-day trading volume of 1.10 million shares is slightly above the 3-month average of 761.06 thousand, indicating heightened recent market interest.

Universal Technical Institute, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.22. This means the shares are trading below this model’s fair value.

Universal Technical Institute, Inc. generated EPS of $0.96 over the past year. Five-year average earnings growth is 84.22%. Wall Street analysts project EPS growth of 5.85% annually over the next five years. The latest quarter delivered EPS of $0.34. The next quarter is forecast at $0.00. Next year's EPS is expected at $29.95. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $38.00 to $35.00. The high target offers 10.47% upside. The low target suggests 1.74% downside. The mean target is $36.10. This offers 4.94% upside. Universal Technical Institute, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 19, 2025, missed forecasts by 29.46%. The prior quarter beat by 58.33%. Over the last six quarters, Apple has recorded several small beats. These include 28.57% in August 06, 2024.

Universal Technical Institute, Inc. has 54.42 million shares outstanding. The public float is 52.94 million shares, elevated short interest at 5.00% of float. This equals 2.31 million shares. The short ratio is 2.55 days. Institutional investors hold 100.22% of the float. Insiders own 2.81%. Coliseum Capital Management, LLC holds 3.97 million shares, STADIUM CAPITAL PARTNERS L P has 2.41 million shares and Grant Jerome Alan has 344.62 thousand shares. Over the past six months, insider transactions show net buying. They sold 1.75 thousand shares across 1 transactions.